N Lguanyl -1,7-diaminoheptane (GC 7) is a potent inhibitor of deoxyhypusine synthase (DHS), the enzyme that catalyzes the first step in the hypusination of eukaryotic translation initiation factor 5A (elF-5A). Since elF-5A is the only known cellular substrate for DHS and GC 7 has been reported to block the proliferation of CHO cells, it has been suggested that DHS may be a novel target for anti-cancer therapy. In the present study we investigated the antiprotiferative effect of GC 7 on several tumorigenic cell lines under various growth conditions. We found that this compound inhibits the proliferation of H9 cells in suspension culture and the growth of HeLa cells and v-src-transformed NIH3T3 cells under both anchorage-dependent and anchorage-independent conditions. Moreover, studies with NIH3T3 cells and v-src-transformed NIH3T3 cells show that GC 7 inhibits the growth of both cell lines in monolayer culture with similar potency and could not reverse the transformed phenotype. In addition, the v-src-transformed cells grown under both anchorage-dependent and anchorage-independent condilions showed similar sensitivity toward GC 7. These data indicate that GC 7 acts as a general antiproliferative agent and does not appear to preferentially target tumorigenic cell types. Cell cycle analysis show that GC 7 reduces the CHO-K1 cell population in the Gl-phase of the cell cycle by 42% and increases the number of cells in the S-phase by 44%. This cell cycle distribution profile strikingly resembles the distribution of cells treated with puromycin. This result supports the hypothesis that the synthesis of a subset of proteins important for the S-phase progression of CHO-KI cells might be dependent upon hypusinated elF-5A. Thus the antiproliferative effect of GC 7 appears to be related to its interference with the progression of cell cycle, which also provides a possible explanation for the lack of selectivity of GC 7 between nontransformed and transformed cell types tested in this study.
Introduction
Deoxyhypusine synthase (DHS) is the first enzyme involved in the hypusination of the eukaryotic translation initiation factor 5A (elF-5A) [1, 2] . It catalyzes the transfer of the 4-aminobutyl moiety of spermidine to the e-amino group of lysine residue 50 in human elF-5A [3] . The deoxyhypusine residue which is formed is then hydroxylated by a second enzyme, deoxyhypusine hydroxylase, to produce hypusinated elF-5A [1, 2] . Recently, a series of synthetic inhibitors of DHS have been identified [4, 5] . NLguanyl-l,7-diaminoheptane (GC7), which is the most potent among them, competitively inhibits the binding of spermidine and has a K i value of 10 nM [4] . Inhibition of [3H]spermidine incorporation into elF-5A by this compound has also been observed in CHO cells [4, 5] . Moreover, GC 7 has been shown to inhibit CHO cell proliferation in culture [5] .
elF-5A is the only known protein in eukaryotic cells that undergoes hypusination, and hypusination of elF-5A has been shown to be essential for the growth of some tumorigenic cell lines [1, 2] . These observations raise the possibility that DHS may be a potential anti-cancer target. We have selected GC 7 to test this hypothesis. Among the known inhibitors of the two enzymes involved in the hypusination of elF-5A, GC 7 is both the most potent and the most specific [4, 5] . Although GC 7 itself is a polyamine analog, it does not significantly affect endogenous polyamine content in CHO cells [5] . It has been shown that the effect of GC 7 is dependent on its uptake by CHO cells and the intact compound is relatively stable within cells [5] . GC 7 inhibits CHO cell proliferation in a concentration-dependent manner and there is a correlation between inhibition of hypusine synthesis and cell growth [5] . It has also been reported that GC 7 did not have a significant early effect on DNA synthesis [5] . Therefore, in the present study we used this compound to investigate whether inhibiting DHS would selectively block the growth of tumorigenic cells.
Materials and methods

Synthesis of N CGuanyl-1, 7-diaminoheptane
GC 7 was synthesized as described by Jakus et al. [4] except that the guanylation was carried out with 1H-pyrazole-l-carboxamidine. Briefly, mono-Z-l,7 diaminoheptane. HBr (2.6 g, 7.5 mmot) was dissolved in 40 ml of DMF in the presence of 1.5 g of 1H-pyrazole-l-carboxamidine monohydrochloride (Fluka) and 4.5 g of N,N ~ Diisopropyl ethylamine. The reaction mixture was warmed to 550C and after 2 h, the DMF was removed in vacuo and the residue applied to a C-18 HPLC column. A gradient of acetonitrile (0-100%) in 0.1% TFA over 90 min at flow rate equal to 75 ml/min was used to isolate l-guanyl, 7-N-Z-heptane. CF3COOH which was eluted at 35 min. Following lyophilization, 2.1 g were obtained.
All chemical intermediates were confirmed by NMR. The theoretical mass of the compound was 173.176622, and the observed mass was 173.176010. The synthesized compound has the same K i value as reported, when assayed in vitro using the partially purified deoxyhypusine synthase from rat testis [3] . . HeLa cells and CHO-K1 cells were purchased from American Type Culture Collection. Cells were maintained in 90% DMEM (NIH3T3 and v-src transformed NIH3T3), or 90% MEM (HeLa) or 90% RPMI 1640 (H9) supplemented with 10% fetal bovine serum (HyClone) or heat-inactivated fetal bovine serum (H9 cells). DMEM, MEM and RPMI 1640 were purchased from Gibco and all media were supplemented with 2 mM glutamine (Gibco) and an antibiotic mixture (Gibco) containing 100 ~g/ml penicillin and 100 /zg/ml streptomycin. Cultures were kept at 37°C in a humidified atmosphere of 5% CO 2 in air. Monolayer cells were split once a week and media were changed twice weekly. H9 cells were maintained in suspension at 10 5 -10 6 cells per ml. Cells were collected either by trypsinizing the monolayer cells or withdrawing an aliquot of suspension cells. Cell numbers were determined using a Coulter counter.
Cell lines and cell culture
To compare the rates of cell growth under different conditions, growth curves were analyzed by linear regression and the slopes (E) of these lines were calculated.
Aminoguanidine, an inhibitor of serum diamine oxidases [6] , was added with GC 7 in all experiments described in this study to prevent the degradation of GC 7. Aminoguanidine alone up to 1 mM did not have any effect on the growth rate or on the viability of the cell lines described in this paper. Thus, for clarity in some figures, only the growth curve of aminoguanidine-treated cells is shown as the control and the one with untreated cells has been omitted.
To determine the cell viability of the monolayer cultured cells, both the floating cells in the culture media and the cells removed from the culture dish by trypsin-treatment were mixed. H9 cells in suspension were collected by centrifugation of the culture. Cell viability was measured by trypan blue staining.
[ 3H]Spermidine incorporation into elF-5A
Exponentially growing cells were incubated with 5-10 /zCi/ml [3H]spermidine (Amersham) in the presence of 1 mM aminoguanidine with or without various amount of GC 7 for 18 h at 37°C in a humidified atmosphere of 5% CO e in air. Cells were harvested by scraping into ice cold phosphate-buffered saline (PBS) containing 1 mM EDTA and collected by centrifugation at 4°C for 5 min at 600 × g. The cells were resuspended in PBS and disrupted by the addition of an equal volume of cold 20% trichloroacetic acid (TCA). The TCA-insoluble material was collected by centrifugation at 3000 X g for 20 min and washed twice with 10% trichloroacetic acid. The precipitate was dissolved in a small volume of 0.25 M NaOH and the protein concentration was determined using the BCA assay (Pierce) with bovine serum albumin as a standard. To determine the [3H]spermidine uptake by cells, duplicate aliquots (10 /xl) from the soluble fraction of each sample were taken and counted in a Beckman scintillation counter. For the autoradiogram 100 /xg protein from each fraction was electrophoresed on 12% polyacrylamide slab gels in the presence of SDS. To detect radiolabeled proteins, the gels were treated with ENTENSIFY (DuPont-New England Nuclear) according to the manufacturer's directions and dried under vacuum. Autoradiography was carried out for 1-2 weeks at -70°C using high-speed film (DuPontNew England Nuclear).
Soft agar assays
Soft agar assays were performed essentially as described [7] . Briefly, HeLa cells were seeded in a 0.3% top agarose layer in its culture medium over a bottom 0.6% agarose layer. Both layers contained the indicated concentrations of GC 7 in the presence of 1 mM aminoguanidine. The cells were fed twice weekly with 0.5 ml medium with or without compound. Photomicrographs were taken 3 weeks after seeding the ccdture.
Cell cycle analysis
The conditions for treating exponentially growing CHO-K1 cells with a variety of compounds known to affect the cell cycle are given in the appropriate figure or table legend. The cells were then trypsinized and collected by centrifugation for 5 min at 300 X g at room temperature. The cells were further processed according to the instructions provided with the CycleTEST PLUS DNA Reagent Kit (Becton Dickinson). Briefly, cells were washed several times and treated with trypsin and RNAse. DNA was then stained with p~ropidium iodide. Samples were analyzed in a Becton Dickinson FACScan flow cytometer system equipped with a doublet discrimination module and two-parameter light-scatter detection. CellFIT software (Becton Dickinson) was used to collect and process the data. Twenty thousand events were usually collected for each sample. Statistical analysis was performed by SFIT, RFIT or SORB model systems in the CellFIT software.
Results
GC 7 inhibits both the anchorage-dependent and the anchorage-independent growth of transformed cell lines
Previous studies have shown that GC 7 is cytostatic to CHO cells growing in monolayer culture [5] . To determine the cell type selectivity of this compound, two transformed cell lines were treated with GC 7 under several growth conditions.
H9 cells, a human T-cell lymphoma line that grows in suspension culture, were treated with 1, 3 or 10 /zM GC 7. The growth curves of H9 cells, representative of 3 independent experiments, are shown in Fig. 1 . GC 7 inhibited the growth of H9 cells in a concentration-dependent manner. While 1 /xM GC 7 had no significant effect on H9 cell proliferation, inhibition of growth became evident with 3 /zM GC 7. At 10 /zM GC 7 H9 cell growth was completely blocked within 1 or 2 days after the addition of the drug. At day 5, when approx. 45% GC 7 remained in the medium, a slight increase in the number of cells was observed. Prolonged growth inhibition (up to two weeks) was achieved, however, when GC 7 was replenished every four days (data not shown). The inhibition of H9 cell proliferation by GC 7 was reversible. Cells treated with 10 /zM GC 7 for 4 days resumed growth after removal of the compound and proliferated at a rate comparable to control cells (Fig. 1A) . These results indicate that a cytostatic mechanism contributes to the antiproliferative effects of GC 7 upon H9 cells. The viability of cells treated with 10 /xM GC 7 for one, two, three and four days, representative of 3 experiments, was 90%, 54 + 2%, 69 ___ 3% and 81 + 1%, respectively, suggesting that the compound also has a cytotoxic effect on H9 cells. This is in contrast to results obtained using CHO cells whose growth was similarly inhibited by 10 /xM GC 7 but with approx. 90% viability (data not shown). When monolayer-cultured HeLa cells were treated with 10 /xM, 30 /xM or 100 p.M GCT, a dose-dependent effect on the growth rate of cells was observed (Fig. 1B) . By comparing the slopes of the growth curves (E) (see Section 2), a quantitative measure of the effect of the drug on cell proliferation is obtained. GC 7 at 30 #M reduced the rate of growth by 20% (Y'. = 0.22 versus 0.27 for the untreated cells). The growth rate of cells treated with 100 /xM GC 7 was decreased by 46% (E = 0.147). Thus, the time required for cell division was increased by 2-fold. The viability of cells treated with 30 /xM or 100 txM GC 7 for one, two or three days was approx. 90%.
The effect of GC 7 on colony formation by HeLa cells in soft agar plates was determined (Fig. 2) . HeLa cells were seeded in soft agar containing GC 7 and colony formation was monitored for a three-week period. At 1 /zM GC 7 no effect on the number and size of the colonies produced by HeLa cells in soft agar compared to the untreated cells was observed ( Fig. 2A,B,C) . When cells were treated with 10 /xM GCT, significantly fewer and smaller colonies were generated (Fig. 2D) . In the presence of 30 /xM GC 7 there were no large colonies and mostly single cells were observed (Fig. 2E) .
GC 7 is not selective for tumorigenic cells
In the case of HeLa cells anchorage-independent cell growth appears to be more sensitive to GC 7 than anchorage-dependent growth. It was, therefore, of interest to determine if this difference was seen in other transformed cell types and whether cells possessing the transformed phenotype are more sensitive to GC 7 than their nontransformed counterparts. To address these points, we tested the effect of GC 7 on a parental NIH3T3 cell line and its counterpart transformed by the v-src oncogene.
NIH3T3 cells display contact-inhibition when grown to high density and cannot grow in soft agar. In contrast, the v-src-transformed counterpart grows without contact inhibition and is anchorage-independent. In monolayer culture, both cell lines grew at a comparable rate (Fig. 3) . When these cells were treated with 10 /zM GCT, there was no effect on the growth rate of either cell line (Fig. 3) . Increasing the concentration of GC 7 to 100 /zM inhibited the growth of NIH3T3 cells by 60% (E = 0.138 5-0.008 versus 0.347 + 0.012 for the untreated cells) (Fig. 3A) and the growth of v-src-transformed NIH3T3 cells by 63% (• = 0.146 5-0.014 versus 0.39 + 0.014 for the untreated cells) (Fig. 3B) . The extent of the inhibition was indistinguishable (P = 0.6366). In addition, GC 7 was not able to reverse the cell morphological changes associated with v-src-transformation (data not shown). Similarly, the morphology of NIH3T3 cells transformed by overexpressing ornithine decarboxylase was not altered by treatment with GC 7 (E. H61tt~i, personal communication). GC 7 also inhibited the anchorage-independent growth of v-src-transformed NIH3T3 cells in soft agar (Fig. 4) . In accord with the concentration-dependent effect of GC7 in monolayer culture, 10 /xM GC 7 had no effect on the number and size of the colonies produced by v-src-transformed NIH3T3 cells in soft agar (Fig. 4D) , while 100 /xM GC 7 completely abolished the ability of these cells to grow on soft agar (Fig. 4E) .
Consistent with the effect of GC 7 on cell growth in both monolayer culture and soft agar and the known ability of GC 7 to inhibit DHS [4] , the incorporation of [3H]spermidine into newly synthesized elF-5A was not appreciably affected by 10 /xM GC 7 but was completely abolished by 100 /xM GC 7 (Fig. 5) . The specific activity of [3H]spermidine in NIH3T3 cells treated with 0, 10 /xM or 100/xM GC 7, expressed as cpm per microgram of total cell protein, was 68200, 72000 and 65500, respectively; in v-src-transformed NIH3T3 cells, it was 70600, 67000 and 62400, respectively. Thus, the inhibition of the hypusination of elF-5A by GC 7 is not simply due to competition for the cellular uptake of spermidine by GC 7.
GC 7 interferes with the progression of the cell cycle
To further characterize the antiproliferative effect of GCT, we analyzed the CHO cell cycle distribution profile in the presence of GC 7 and compared it to the profile of untreated cells as well as to those obtained from cells treated with several compounds whose effects on the CHO cell cycle are well known. These compounds included DFMO, a specific inhibitor of ornithine decarboxylase [8] , mimosine, a metal chelator, also reported to inhibit deoxyhypusine hydroxylase [9] and two protein synthesis inhibitors, cycloheximide [10] and puromycin [11 ] . Exponentially growing CHO-KI cells were treated with these agents at the concentrations indicated in Table 1 . Cells were harvested either one or three days after the treatment and processed as described in Section 2. To quantitate the percentage of cells in each phase of the cell cycle, propidium iodide-stained cell nuclei were analyzed in a FACScan flow cytometer. These results are summarized in Table 1 and representative examples of the DNA histograms are shown in Fig. 6 . GC 7 at a concentration of 10 #M reduced the cell population in Gl-phase by 42% and increased the number of cells in S-phase by 44% (Table 1 and Fig. 6C, 6D ). This concentration of GC 7 was also required to inhibit CHO-K1 cell proliferation and [3 H]spermidine incorporation into eIF-5A (data not shown). In contrast to the effect of GC7, three of the reference compounds which were tested, DFMO (Table 1 and Fig.  6E ), mimosine (Table 1 and Fig. 6F ) and cycloheximide (Table 1 and Fig. 6G ) increased the number of cells in Gl-phase by 82%, 86% and 55%, respectively, and reduced the cell population in S-phase by 77%, 73% and 40%, respectively. In contrast, the DNA histogram of puromycin-treated cells, unlike that for cycloheximidetreated cells, showed a reduced number of cells in Gl-phase (by 43%) and an increased cell population in S-phase (by 33%). Thus, the DNA histogram profile of puromycin- Table 1 Effect of GC 7 on CHO-K1 cell cycle distribution
a, number of separate experiments. b, no viable cells. Cells were treated with various agents for the indicated length of time.
They were collected and processed as described in Section 2. Propidium iodide-stained nuclei were then analyzed in a FACScan flow cytometer to obtain a DNA histogram. The percentage of cells distributed in each phase of cell cycle was calculated from the DNA histogram using SFIT, RFIT or SORB model systems in the CellFIT software. Values in the table represent means_S.E.M, from at least 4 samples from 2 or 3 independent experiments. The values in parenthesis indicate the percent change in the fraction of cells in that phase of the cell cycle compared to the fraction of cells in the same phase of the cell cycle from the untreated samples, except that the percent change in GC7-treated cells was calculated using the value from aminoguanidine-treated cells as control. treated cells closely resembled that observed for GC 7-treated cells (Table 1 and Fig. 6H ).
Discussion
Hypusination of elF-5A has been reported to be required for the growth of eukaryotic cells [1, 2, 12, 13] and inhibitors of DHS, the first enzyme involved in the hypusination reaction, block the proliferation of CHO cells [4, 5] . On this basis it was proposed that these inhibitors might have practical application as chemotherapeutic agents against tumor cells [5] . The effects of GC 7 observed on the two human tumor cell lines, H9 and HeLa, in this study support this proposal. However, from our initial data it was unclear whether or not the growth of tumorigenic cell lines is more sensitive to the depletion of hypusinated elF-5A than normal cells, and, therefore, whether or not inhibiting DHS would selectively block the growth of tumorigenic cell lines. To address this question, we have investigated the effect of GC7, a potent inhibitor of DHS, on a nontransformed parental NIH3T3 cell line and its highly tumorigenic counterpart transformed by the v-src oncogene. GC 7 inhibited the growth of NIH3T3 and v-src-transformed NIH3T3 cell lines in monolayer culture with a similar potency. The dose-dependent inhibition of hypusination of newly synthesized cellular elF-5A by GC 7 was also similar for both cell lines. Therefore, GC 7 has no selective growth inhibitory effect on v-src-transformed NIH3T3 cells in monolayer culture. In addition, GC 7 failed to reverse the phenotypical changes mediated by v-src transformation. This lack of an effect does not appear to be specific to the mechanism of transformation by v-src, since NIH3T3 cells transformed by overexpressing ornithine decarboxylase showed similar results. Moreover, the same concentration of GC 7 required to inhibit v-srctransformed NIH3T3 cells in monolayer culture was needed to block colony formation of these cells in soft agar plates. This further suggests that the anti-neoplastic property of GC 7 against tumorigenic cells growing on soft agar is likely due to its general antiproliferative effect. The difference in the concentration of GC 7 needed to inhibit the growth of HeLa cells in monolayer culture versus on soft agar plates could result simply from the more stressful growth conditions in soft agar which could in turn increase the susceptibility of these cells to GCT, or more specifically from a mechanism related to anchorage-independent growth which is unique to HeLa cells. Notwithstanding this particular result, the data suggest that the effect of GC 7, and perhaps other inhibitors of deoxyhypusine synthase, is primarily on cell proliferation, and not on cellular transformation.
This antiproliferative property of deoxyhypusine synthase inhibitors is distinct from inhibitors of farnesyl-transferase for example, which have been shown to rapidly reverse the Ras oncogene transformed phenotype without affecting general cell proliferation [7] . However, this property of GC 7 is similar to many anti-cancer agents currently in the clinic which have anti-neoplastic actions, such as antimetabolites, DNA-binding antibiotics, platinum analogs and alkylating agents. Whether the antiproliferative effect achieved through inhibiting deoxyhypusine synthase provides additional advantages over the other approaches used in the clinic will require further investigation.
The data from cell cycle analysis showed that CHO-K1 cells treated with GC 7 accumulated in the S-phase of the cell cycle. This implies that there might be a subset of proteins whose synthesis is sensitive to the inhibition of DHS and is required for the progression of CHO cells through S-phase. Evidence for such a subset of proteins is provided by a recent study with mimosine that showed the existence of a subset of mRNAs whose association with polysomes was correlated with the degree of hypusination of eIF-5A [16] . Interestingly, the cell cycle distribution profile of GCT-treated CHO-K1 cells closely resembles the one mediated by puromycin and is distinct from the patterns observed after treatment with DFMO, mimosine or cycloheximide. Although puromycin and cycloheximide are both protein synthesis inhibitors, they give rise to distinct cell cycle distribution profiles. This could be explained by previously reported differential effects of these two compounds on the synthesis of specific subsets of proteins in cells [11, 14, 15] . The similarity between the cell cycle distribution profile generated by treatment with puromycin or GC 7 raises the possibility that the inhibition of the synthesis of a subset of proteins in the presence of GC 7 may overlap with the set of proteins whose synthesis is particularly sensitive to puromycin.
Both DFMO and mimosine are compounds that inhibit hypusination of elF-5A [1, 2] . The former exerts its effect by reducing the intracellular supply of spermidine [17] ; the latter inhibits deoxyhypusine hydroxylase [9] . Blockades at either G I or S-phase of the cell cycle have been reported with DFMO treatment [8, [18] [19] [20] [21] and inhibition of the hydroxylation of other proteins by mimosine has also been shown [22] . Thus, it appears that each of these agents interferes with the synthesis or function of multiple proteins and the effect of either of these compounds on the cell cycle could be the net result of their inhibition of several cellular processes. In the case of DFMO and GCT, the difference in the effects on the CHO cell cycle between these compounds observed in this study may be attributable to targeting at a position further upstream in the biosynthetic pathway of polyamines by DFMO. This could easily result in a different spectrum of proteins affected by each drug. In general, attempting to analyze the cellular effects of drugs that alter the biosynthesis of hypusinated eIF-5A will be complex. The existence of multiple forms of eIF-5A, for example, hypusinated, deoxyhypusinated (in the presence of mimosine) and non-hypusinated (in the presence of GC 7 or DFMO), and their relative ability to modulate different cell function as well as their relative levels in cells may all be important factors. This could explain in part the difference in the effects on cell cycle seen between GC 7 and mimosine.
In summary, our data suggest that, by inhibiting hypusination of eIF-5A, GC 7 may affect the synthesis of several proteins and, thus, these experiments provide an explanation for the lack of significant selectivity displayed by GC 7 for the cell lines tested in this study. We recognize that it is also possible that some of the cellular effects of GC 7 may not be related to its effect on the hypusination of eIF-5A. While the precise mechanism for the effect of GC 7 off the cell cycle remains to be elucidated, it is likely that interference with the progression of the cell cycle by GC 7 accounts for its antiproliferative effect.
